2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | - | 0 | 0 | 9.552 | 74.615 | 56.112 | 156.637 | 240.966 | 278.567 | 259.930 |
Total Income - EUR | - | 0 | 21.827 | 17.214 | 74.615 | 61.736 | 187.706 | 244.656 | 282.279 | 263.621 |
Total Expenses - EUR | - | 0 | 30.766 | 38.823 | 62.473 | 68.736 | 158.999 | 199.661 | 216.386 | 219.433 |
Gross Profit/Loss - EUR | - | 0 | -8.940 | -21.609 | 12.142 | -7.000 | 28.707 | 44.995 | 65.893 | 44.188 |
Net Profit/Loss - EUR | - | 0 | -8.940 | -21.737 | 11.450 | -7.561 | 27.254 | 42.884 | 63.163 | 41.641 |
Employees | - | 0 | 0 | 2 | 2 | 2 | 2 | 4 | 5 | 5 |
Check the financial reports for the company - Belo Vet S.r.l.
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | - | 0 | 0 | 8.417 | 27.471 | 20.757 | 16.230 | 16.235 | 33.767 | 25.718 |
Current Assets | - | 45 | 22.100 | 6.641 | 14.871 | 53.514 | 39.716 | 75.318 | 65.352 | 115.089 |
Inventories | - | 0 | 0 | 926 | 13.110 | 29.149 | 18.007 | 6.617 | 11.400 | 27.594 |
Receivables | - | 0 | 0 | 0 | 996 | 23.153 | 1.390 | 1.938 | 4.173 | 94.774 |
Cash | - | 45 | 22.100 | 5.715 | 764 | 1.211 | 20.319 | 66.763 | 49.779 | -7.279 |
Shareholders Funds | - | 45 | -8.895 | -30.481 | -18.471 | -7.965 | 19.440 | 61.893 | 63.211 | 104.660 |
Social Capital | - | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | - | 0 | 30.995 | 45.539 | 60.813 | 34.072 | 20.324 | 17.607 | 27.437 | 31.390 |
Income in Advance | - | 0 | 0 | 0 | 0 | 48.164 | 16.182 | 12.134 | 8.471 | 4.756 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "7500 - 7500" | |||||||||
CAEN Financial Year |
7500
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Belo Vet S.r.l.